BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1444 related articles for article (PubMed ID: 16079795)

  • 1. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
    Willmann D; Lim S; Wetzel S; Metzger E; Jandausch A; Wilk W; Jung M; Forne I; Imhof A; Janzer A; Kirfel J; Waldmann H; Schüle R; Buettner R
    Int J Cancer; 2012 Dec; 131(11):2704-9. PubMed ID: 22447389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylation and androgen-dependent transcription.
    Metzger E; Wissmann M; Schüle R
    Curr Opin Genet Dev; 2006 Oct; 16(5):513-7. PubMed ID: 16919442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
    Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
    Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
    Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
    Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
    Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
    Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.
    Metzger E; Yin N; Wissmann M; Kunowska N; Fischer K; Friedrichs N; Patnaik D; Higgins JM; Potier N; Scheidtmann KH; Buettner R; Schüle R
    Nat Cell Biol; 2008 Jan; 10(1):53-60. PubMed ID: 18066052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation.
    Lee MG; Wynder C; Cooch N; Shiekhattar R
    Nature; 2005 Sep; 437(7057):432-5. PubMed ID: 16079794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing the histone code on LSD1.
    Gamble MJ; Kraus WL
    Cell; 2007 Feb; 128(3):433-4. PubMed ID: 17289562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of LSD1 histone demethylase activity by its associated factors.
    Shi YJ; Matson C; Lan F; Iwase S; Baba T; Shi Y
    Mol Cell; 2005 Sep; 19(6):857-64. PubMed ID: 16140033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.
    Yang M; Culhane JC; Szewczuk LM; Gocke CB; Brautigam CA; Tomchick DR; Machius M; Cole PA; Yu H
    Nat Struct Mol Biol; 2007 Jun; 14(6):535-9. PubMed ID: 17529991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
    Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
    Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1 demethylates histone and non-histone proteins.
    Nicholson TB; Chen T
    Epigenetics; 2009 Apr; 4(3):129-32. PubMed ID: 19395867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.